Retatrutide
A pharmaceutical drug, mentioned as an 'artificial solution to an artificial food landscape,' drawing a parallel to AI as an artificial solution to problems created by technology.
Expert discussions of Retatrutide across 7 podcasts.
Build a research pod, ask cited questions across all of them, and connect it to Claude or ChatGPT.
Common Themes
Videos Mentioning Retatrutide
How To Go Hard, Even When You Don’t Want To - Sam Sulek
Chris Williamson
A GLP-1/GIP/glucagon receptor triple agonist, discussed in the context of its impact on the peptide market and comparison to other interventions.
AI Expert Warns: “This Is The Last Mistake We’ll Ever Make” - Tristan Harris
Chris Williamson
A pharmaceutical drug, mentioned as an 'artificial solution to an artificial food landscape,' drawing a parallel to AI as an artificial solution to problems created by technology.
Eating Hacks, Best Foods & High IQ Training Methods - Dr Mike Israetel
Chris Williamson
A fifth-generation triple agonist (GLP-1, GIP, glucagon) in clinical trials that is significantly more effective for weight loss with fewer side effects than previous generations.
Peptides: The Science, Uses & Safety | Dr. Abud Bakri
Andrew Huberman
A triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors, with significant potential for weight loss.
Dr. Andrew Huberman — Peptides, Performance, and Protocols
Tim Ferriss
A novel GLP-GIP-Glucagon system impactor from Lilly, expected to be highly effective for weight loss, potentially sparing muscle.
403 ‒ Peptides: separating scientific promise from marketing hype
Peter Attia MD
Mentioned as a peptide with a powerful story around it, and as an example of a molecule where manufacturing and purification are critical for pharmaceutical use.
Best Tools for Gut Health & Weight Loss | Dr. Chris Thompson
Andrew Huberman
A multi-agonist drug that promotes GLP, GIP, and glucagon, showing promising results (30% body weight reduction) in clinical trials and potentially offering muscle-sparing benefits and synergistic effects with GLP-1s.